Financial Partners Group, Inc Danaher Corp Transaction History

Financial Partners Group, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $20,762 - $24,276	-86 Reduced 9.98%	776 $205,000
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $247 - $1,507	1 Added 0.12%	862 $223,000
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $24,185 - $30,565	102 Added 13.44%	861 $218,000
Q1 2022 Apr 29, 2022	SELL	$257.27 - $315.76 $13,892 - $17,051	-54 Reduced 6.64%	759 $223,000
Q4 2021 Feb 10, 2022	SELL	$292.08 - $329.01 $14,896 - $16,779	-51 Reduced 5.9%	813 $232,000
Q3 2021 Nov 05, 2021	BUY	$272.21 - $332.43 $9,799 - $11,967	36 Added 4.35%	864 $263,000
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $186,366 - $224,959	828 New	828 $222,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Financial Partners Group, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Partners Group, Inc with notifications on news.